Deutsche Bank upgrades Healthpeak Properties stock to Buy, citing improved leasing outlook and raised FFO estimates for 2025 ...

Ronald Kamdem, an analyst from Morgan Stanley, maintained the Hold rating on Healthpeak Properties (DOC – Research Report). The ...

Healthpeak Properties has a diversified portfolio with strong occupancy rates in MOBs and lab facilities. Read why DOC stock ...

Mizuho Securities analyst Vikram Malhotra has reiterated their bullish stance on DOC stock, giving a Buy rating today. Vikram Malhotra’s ...

In Q3, Healthpeak demonstrated substantial leasing momentum, executing 465,000 square feet in lease agreements with life ...

Healthpeak Properties raised the lower-end of its annual funds from operations (FFO) forecast on Thursday, banking on steady demand for its medical office and life science properties.

Healthpeak Properties, Inc. (NYSE: DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, today announce ...

Fintel reports that on October 21, 2024, Deutsche Bank upgraded their outlook for Healthpeak Properties (NYSE:DOC) from Hold ...

Healthpeak Properties, Inc. DOC reported third-quarter 2024 funds from operations (FFO) as adjusted per share of 45 cents, ...

The health care real estate investment trust, based in Denver, posted revenue of $700.4 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $689 million.

Throughout the last three months, 8 analysts have evaluated Healthpeak Properties (NYSE:DOC), offering a diverse set of opinions from bullish to bearish. The following table encapsulates their ...

Healthpeak Properties Trading Down 2.0 % Shares of Healthpeak Properties stock opened at $22.18 on Tuesday. Healthpeak Properties has a 1-year low of $15.24 and a 1-year high of $23.14. The ...